◼ Archived
Business
🔮 Archynetys predicts: fades by tomorrow — graded ✓ correct
The loophole in Trump’s obesity drug deal with Eli Lilly and Novo Nordisk
0sources
0articles
0velocity
20d agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (0)
From around our network
- Pocket Veto, Explained: Why Trump's Housing Bill Snub Wasn't One daybreakwire.com
Related trends
▲ Peaking
Business
Google launches Gemini 3.6 Flash and 3.5 Flash-Lite, teases Gemini 4
Google has expanded its AI portfolio with three new lightweight Gemini models while teasing the upcoming Gemini 4.
▲ Peaking
Business
Unpacking Anthropic's 100-day sprint into biopharma: Nobel hires, M&A and major ambition
▲ Peaking
Business
Archer Aviation Stock Soars 20% on New Defense Deal
▲ Peaking
Business
Cracker Barrel sells Maple Street Biscuit Co.
▲ Peaking
Business
SpaceX sets earnings date, triggering first lock-up expiration for millions of shares
SpaceX is preparing for its first earnings report on August 4, coinciding with a massive $116 billion release of insider shares.
▲ Peaking
Business